Salmeterol Xinafoate

API Product
Product Status:
Available Grades:
  • Inhalation
Regulatory Status:
Production Sites:
  • Hovione Loures
Product Type:
  • LABA
  • LAMA
CAS Number:
Modes of Application:
  • Inhalation
Common Indications:
  • Asthma
  • COPD
Last Inspection:
FDA May 2018

Hovione can customize Salmeterol Xinafoate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.

Hovione Salmeterol Xinafoate is approved in generic applications.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Fluticasone Propionate.




This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.


Contact Us

Please contact us if you have inquiries about our offering

Related files

Hovione - Integrated Product List
pdf (3.23 MB)